You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

CHLORAMPHENICOL SODIUM SUCCINATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Chloramphenicol Sodium Succinate patents expire, and when can generic versions of Chloramphenicol Sodium Succinate launch?

Chloramphenicol Sodium Succinate is a drug marketed by Fresenius Kabi Usa and Gruppo Lepetit and is included in two NDAs.

The generic ingredient in CHLORAMPHENICOL SODIUM SUCCINATE is chloramphenicol sodium succinate. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the chloramphenicol sodium succinate profile page.

US Patents and Regulatory Information for CHLORAMPHENICOL SODIUM SUCCINATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa CHLORAMPHENICOL SODIUM SUCCINATE chloramphenicol sodium succinate INJECTABLE;INJECTION 062365-001 Aug 25, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Gruppo Lepetit CHLORAMPHENICOL SODIUM SUCCINATE chloramphenicol sodium succinate INJECTABLE;INJECTION 062278-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.